
Hubert C. Lorin
Examiner (ID: 8123)
| Most Active Art Unit | 1307 |
| Art Unit(s) | 1307, 2899 |
| Total Applications | 717 |
| Issued Applications | 500 |
| Pending Applications | 0 |
| Abandoned Applications | 217 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9099161
[patent_doc_number] => 08563033
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-10-22
[patent_title] => 'Orally effective methylphenidate extended release powder and aqueous suspension product'
[patent_app_type] => utility
[patent_app_number] => 13/905808
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18861
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905808
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/905808 | Orally effective methylphenidate extended release powder and aqueous suspension product | May 29, 2013 | Issued |
Array
(
[id] => 9019965
[patent_doc_number] => 08529948
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-09-10
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 13/905931
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20213
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905931
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/905931 | Pharmaceutical formulation containing gelling agent | May 29, 2013 | Issued |
Array
(
[id] => 9551780
[patent_doc_number] => 08758825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Sequestered antagonist formulations'
[patent_app_type] => utility
[patent_app_number] => 13/900044
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27615
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900044
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900044 | Sequestered antagonist formulations | May 21, 2013 | Issued |
Array
(
[id] => 9551780
[patent_doc_number] => 08758825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Sequestered antagonist formulations'
[patent_app_type] => utility
[patent_app_number] => 13/900044
[patent_app_country] => US
[patent_app_date] => 2013-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27615
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900044
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/900044 | Sequestered antagonist formulations | May 21, 2013 | Issued |
| 13/892225 | TREATMENT FOR CHRONIC KIDNEY DISEASE | May 9, 2013 | Abandoned |
Array
(
[id] => 13011635
[patent_doc_number] => 10028918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/399335
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11100
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399335
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/399335 | Nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine and uses thereof | Apr 30, 2013 | Issued |
Array
(
[id] => 9756341
[patent_doc_number] => 20140287042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'Oral Tablet Formulation Consisting Of Fixed Combination Of Rosuvastatin And Ezetimibe For Treatment Of Hyperlipidemia And Cardiovascular Diseases'
[patent_app_type] => utility
[patent_app_number] => 14/350905
[patent_app_country] => US
[patent_app_date] => 2013-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3842
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350905
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350905 | Oral tablet formulation consisting of fixed combination of rosuvastatin and ezetimibe for treatment of hyperlipidemia and cardiovascular diseases | Apr 30, 2013 | Issued |
Array
(
[id] => 9147740
[patent_doc_number] => 20130302263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'BLOCK TYPE-MODIFIED ORGANOPOLYSILOXANE, METHOD FOR USING THE ORGANOPOLYSILOXANE, COSMETIC, AND METHOD FOR PRODUCING THE ORGANOPOLYSILOXANE'
[patent_app_type] => utility
[patent_app_number] => 13/868235
[patent_app_country] => US
[patent_app_date] => 2013-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11264
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13868235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/868235 | Block type-modified organopolysiloxane, method for using the organopolysiloxane, cosmetic, and method for producing the organopolysiloxane | Apr 22, 2013 | Issued |
Array
(
[id] => 10208464
[patent_doc_number] => 20150093454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'COMPOSITION COMPRISING ALPHA-LIPOIC ACID AND HONOKIOL FOR TREATING NEUROPATHIES'
[patent_app_type] => utility
[patent_app_number] => 14/395265
[patent_app_country] => US
[patent_app_date] => 2013-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4741
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395265
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/395265 | Composition comprising alpha-lipoic acid and honokiol for treating neuropathies | Apr 18, 2013 | Issued |
Array
(
[id] => 9160999
[patent_doc_number] => 20130309276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same'
[patent_app_type] => utility
[patent_app_number] => 13/858677
[patent_app_country] => US
[patent_app_date] => 2013-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25604
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858677
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/858677 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | Apr 7, 2013 | Abandoned |
Array
(
[id] => 9139847
[patent_doc_number] => 08580303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Gastric retained gabapentin dosage form'
[patent_app_type] => utility
[patent_app_number] => 13/854433
[patent_app_country] => US
[patent_app_date] => 2013-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5540
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854433
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/854433 | Gastric retained gabapentin dosage form | Mar 31, 2013 | Issued |
Array
(
[id] => 9538462
[patent_doc_number] => 20140163109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'TASTE-MASKED IBUPROPEN GRANULES'
[patent_app_type] => utility
[patent_app_number] => 14/239995
[patent_app_country] => US
[patent_app_date] => 2013-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9636
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239995
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239995 | TASTE-MASKED IBUPROPEN GRANULES | Mar 25, 2013 | Abandoned |
Array
(
[id] => 9895134
[patent_doc_number] => 20150050333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT'
[patent_app_type] => utility
[patent_app_number] => 14/388115
[patent_app_country] => US
[patent_app_date] => 2013-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8722
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388115 | PHARMACEUTICAL COMPOSITION COMPRISING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT | Mar 21, 2013 | Abandoned |
Array
(
[id] => 8989315
[patent_doc_number] => 20130216596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'NANOCAPSULES CONTAINING MICROEMULSIONS'
[patent_app_type] => utility
[patent_app_number] => 13/848558
[patent_app_country] => US
[patent_app_date] => 2013-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17275
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/848558 | Nanocapsules containing microemulsions | Mar 20, 2013 | Issued |
Array
(
[id] => 8989342
[patent_doc_number] => 20130216623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'APPARATUS AND FORMULATIONS FOR SUPRACHORIDAL DRUG DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/842218
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7676
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13842218
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/842218 | APPARATUS AND FORMULATIONS FOR SUPRACHORIDAL DRUG DELIVERY | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9054068
[patent_doc_number] => 20130251782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-26
[patent_title] => 'TOPICAL APPLICATION OF INGENOL MEBUTATE WITH OCCLUSION'
[patent_app_type] => utility
[patent_app_number] => 13/839975
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9121
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13839975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/839975 | TOPICAL APPLICATION OF INGENOL MEBUTATE WITH OCCLUSION | Mar 14, 2013 | Abandoned |
Array
(
[id] => 11407722
[patent_doc_number] => 09555007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates'
[patent_app_type] => utility
[patent_app_number] => 13/831250
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 13737
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13831250
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/831250 | Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates | Mar 13, 2013 | Issued |
Array
(
[id] => 9095041
[patent_doc_number] => 20130274352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'Oral Drug Devices and Drug Formulations'
[patent_app_type] => utility
[patent_app_number] => 13/802079
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 19183
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13802079
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/802079 | Oral Drug Devices and Drug Formulations | Mar 12, 2013 | Abandoned |
Array
(
[id] => 8939413
[patent_doc_number] => 20130189210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'OIL-IN-WATER COSMETIC'
[patent_app_type] => utility
[patent_app_number] => 13/801258
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7670
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13801258
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/801258 | OIL-IN-WATER COSMETIC | Mar 12, 2013 | Abandoned |
Array
(
[id] => 11407703
[patent_doc_number] => 09554989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'Silk reservoirs for drug delivery'
[patent_app_type] => utility
[patent_app_number] => 14/386545
[patent_app_country] => US
[patent_app_date] => 2013-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 30290
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14386545
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/386545 | Silk reservoirs for drug delivery | Mar 10, 2013 | Issued |